← Back to Search

Behavioral Intervention

Resilience-Building Intervention for Advance Care Planning

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Having a cancer diagnosis or a heart failure diagnosis documented in the electronic medical record
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately at the end of the usability testing
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to address the low completion rate of advance directives among Chinese Americans compared to the general US population. The researchers will develop a culturally tailored intervention to help Chinese Americans with cancer or heart disease and

Who is the study for?
This trial is for Chinese Americans over 18 with cancer or heart failure who have a family caregiver willing to join the study. Participants must be able to respond in English or Mandarin and have their diagnosis recorded in medical records.
What is being tested?
The study aims to develop and test a resilience-building intervention tailored for Chinese Americans, focusing on improving advance care planning discussions among patients with cancer or heart disease and their caregivers.
What are the potential side effects?
Since this is not a drug trial but an intervention focused on communication and planning, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My diagnosis of cancer or heart failure is officially recorded.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately at the end of the usability testing
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately at the end of the usability testing for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Participants will evaluate the culturally-tailored resilience-building intervention prototype

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,568,760 Total Patients Enrolled
University of ChicagoOTHER
1,057 Previous Clinical Trials
763,595 Total Patients Enrolled
Rush University Medical CenterOTHER
436 Previous Clinical Trials
249,216 Total Patients Enrolled
~11 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top